Lipid Infusions to Optimize Nutrition Trial
NCT06915441 · Status: RECRUITING · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 230
Last updated 2026-05-05
Summary
The purpose of this study is to identify survival free of bronchopulmonary dysplasia (BPD), fatty acid profiles, and early biochemical measures for oxidative stress comparing mixed oil lipid emulsion (MOLE) vs soybean oil-based lipid emulsion (SOLE) and to establish whether MOLE or SOLE is more effective in minimizing pulmonary outcomes, neonatal morbidities, long-term morbidity and mortality, and improving discharge growth and Bayley Scales of Infant Development Fourth Edition (BSID-IV) neurodevelopmental assessment at two years
Conditions
- Bronchopulmonary Dysplasia
- Neurodevelopmental Impairment
Interventions
- DRUG
-
SOLE
Participants will first receive LE at 1 g/kg/day, then will advance to 2 g/kg/day and lastly to 3 g/kg/day as tolerated to titrate based on triglyceride level \<250 mg/dL, per clinical team
- DRUG
-
MOLE
Participants will first receive LE at 1 g/kg/day, then will advance to 2 g/kg/day and lastly to 3 g/kg/day as tolerated to titrate based on triglyceride level \<250 mg/dL, per clinical team
Sponsors & Collaborators
-
The University of Texas Health Science Center, Houston
lead OTHER
Principal Investigators
-
Lindsay Holzapfel, MD, MS · The University of Texas Health Science Center, Houston
Study Design
- Allocation
- RANDOMIZED
- Purpose
- OTHER
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 12 Hours
- Max Age
- 28 Weeks
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2026-05-01
- Primary Completion
- 2028-07-30
- Completion
- 2030-12-31
- FDA Drug
- Yes
Countries
- United States
Study Locations
More Related Trials
-
Effectiveness of Multicomponent Lipid Emulsion in Preterm Infants Requiring Parenteral Nutrition
NCT02663453 ·Status: COMPLETED ·Phase: PHASE3
-
Introduction and Maintenance of Still Eating Protein Blends in Support of Infant Nutritional Goals
NCT03667118 ·Status: COMPLETED ·Phase: NA
-
Optimizing Individual Nutrition in Preterm Very Low Birth Weight Infants
NCT02372136 ·Status: COMPLETED ·Phase: NA
-
Targeted Protein Fortification in Extremely Low Birth Weight Preterm Infants
NCT02943746 ·Status: COMPLETED ·Phase: NA
-
Impact of Implementing an Infant Driven Feeding Program on Oral Feeding and Growth Outcomes of Medically Fragile Infants in the Neonatal ICU (NICU)
NCT01666457 ·Status: COMPLETED
-
Effect of the Level of Dietary Protein on the Infant Hormonal Profile and Body Composition
NCT02282488 ·Status: COMPLETED ·Phase: NA
-
Clinical Effects of a Formula With Modified Protein Levels and Fat Blend in Preterm Infants
NCT03055052 ·Status: COMPLETED ·Phase: NA
-
A Double-blind Randomized Controlled Trial of a Thickened Amino-acid-based Formula in Children Allergic to Cow's Milk and to Protein Hydrolysates
NCT01940068 ·Status: COMPLETED ·Phase: NA
-
Can SMOFlipid®, A Composite Parenteral Nutrition Lipid Emulsion, Prevent Progression Of Parenteral Nutrition Associated Liver Disease In Infants?
NCT00793195 ·Status: UNKNOWN ·Phase: PHASE2
-
Feeding Tolerance and Growth of Preterm Infants Consuming a Supplement Containing Two Human Milk Oligosaccharides (HMOs)
NCT06212427 ·Status: RECRUITING ·Phase: NA
-
Infant Formula Supplemented With a Special Fat Formulation for Premature Infants Following Discharge From Hospital
NCT01140243 ·Status: COMPLETED ·Phase: NA
-
Effect of Extensively Hydrolyzed Liquid Human Milk Fortifier on Growth and Tolerance in Moderately Premature Infants
NCT02632266 ·Status: COMPLETED ·Phase: PHASE4
-
Dietary Protein in the Very-low-birth-weight Infant
NCT01208493 ·Status: TERMINATED ·Phase: NA
-
Early Provision of Enteral Microlipid and Fish Oil to Infants With Enterostomy
NCT01306838 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Feeding Tolerance in Preterm Infants
NCT00450697 ·Status: UNKNOWN
-
Evaluation of Tolerance, Efficacy and Safety of an Hydrolyzed Formula in Infants With IgE/Non-IgE Mediated CMA.
NCT06481280 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Evaluation of a Standard Preterm Infant Formula Fed to Preterm Infants in the Hospital
NCT01766011 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Low Dose Parenteral Fat for Prevention of Parenteral Nutrition Associated Cholestasis in Preterm Neonates
NCT01050660 ·Status: COMPLETED ·Phase: NA
-
High-energy Human Milk Diets in the First Two Weeks After Birth to Reduce BPD in Extremely Preterm Infants
NCT07307612 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1/PHASE2
-
Acceptability and Tolerance Study of an Amino Acid Formula with HMOs
NCT04575298 ·Status: TERMINATED
-
Early Supplementation of Enteral Microlipid With and Without Fish Oil in Premature Infants With Enterostomies
NCT01674478 ·Status: COMPLETED ·Phase: PHASE2
-
Hydrolized Protein Formula for Premature Infants
NCT01156493 ·Status: COMPLETED ·Phase: NA
-
Medical Nutrition Therapy for Medically Complex Infants in the Pediatric Outpatient Setting
NCT03522558 ·Status: UNKNOWN ·Phase: NA
-
Targeted Nutrition for Moderate to Late Preterm Infants
NCT05515614 ·Status: COMPLETED ·Phase: NA
-
Evaluation of the Efficacy of an Amino Acid Based Formula in Infants
NCT01584245 ·Status: TERMINATED ·Phase: NA